Sims Karen 4
4 · Arbutus Biopharma Corp · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Sims Karen
Chief Medical Officer
Transactions
- Award
Common Shares
2025-02-14+49,300→ 155,494 total - Award
Stock Option (Right to Buy)
2025-02-14+200,300→ 200,300 totalExercise: $3.29Exp: 2035-02-14→ Common Shares (200,300 underlying)
Footnotes (3)
- [F1]Represents the grant of restricted stock units ("RSUs"), which represent a contingent right to receive one common share for each RSU. The RSUs vest in three equal annual installments beginning one year from the grant date, subject to the Reporting Person's continuous service as of each vesting date. Unless otherwise provided, on each vesting date, common shares will automatically be sold to satisfy the Reporting Person's tax withholding obligations in a non-discretionary transaction.
- [F2]Reflects the closing price of the Company's common shares on the Nasdaq Stock Market on the date of the grant.
- [F3]This option vests over a four-year period, with 1/48th of the shares subject to the option vesting in substantially equal monthly installments measured from one month following the grant date, subject to the Reporting Person's continuous service as of each vesting date.